The Chronicle of Higher Education

Journals Resist a Drug Company's Subpoenas, Citing the Threat to Peer Review

Grandiose language has appeared in the pages of medical journals this month, as well as in federal court, about a looming threat to peer review.

The threat comes in the form of subpoenas from the pharmaceutical giant Pfizer requesting confidential peer reviews and editors' comments about...

To continue reading this premium article, you must have a Chronicle account AND a subscription or an online pass.

Subscriptions start at $40; Web passes for under $10.